BioHealth News

University vs. industry: Boston gathering takes on biotech’s longstanding divide – Boston Business Journal

University vs. industry: Boston gathering takes on biotech’s longstanding divide – Boston Business Journal

Read More
A Johns Hopkins team designed an Ebola suit so good, it’s going on the market – The Washington Post

A Johns Hopkins team designed an Ebola suit so good, it’s going on the market – The Washington Post

Read More
Expanding the Reach of Precision Medicine – Promising Practices – Management – GovExec.com

Expanding the Reach of Precision Medicine – Promising Practices – Management – GovExec.com

Read More
Pittsburgh Life Sciences Greenhouse Accelerator Fund II closes on $4 million, could raise as much as $12 million – Pittsburgh Business Times

Pittsburgh Life Sciences Greenhouse Accelerator Fund II closes on $4 million, could raise as much as $12 million – Pittsburgh Business Times

Read More
Sisu Global Heath wins $100,000 investment from AOL co-founder Steve Case – Baltimore Sun

Sisu Global Heath wins $100,000 investment from AOL co-founder Steve Case – Baltimore Sun

Read More
Roche Drug First to Clear Clinical Trials for Hard-to-Treat Form of Multiple Sclerosis – Scientific American

Roche Drug First to Clear Clinical Trials for Hard-to-Treat Form of Multiple Sclerosis – Scientific American

Read More
NIH Wants to License Out a Mobile App to the Private Sector – Nextgov.com

NIH Wants to License Out a Mobile App to the Private Sector – Nextgov.com

Read More
The beginning of Precision Medicine marks the beginning of the end of common diseases…

The beginning of Precision Medicine marks the beginning of the end of common diseases…

Read More
Vtesse, Inc. Initiates Phase 2b/3 Clinical Trial of VTS-270 for Treatment of Niemann-Pick Type C1 (NPC) Disease

Vtesse, Inc. Initiates Phase 2b/3 Clinical Trial of VTS-270 for Treatment of Niemann-Pick Type C1 (NPC) Disease

Read More
‘Megafund’ proposed to spur drug development for rare disease – The Boston Globe

‘Megafund’ proposed to spur drug development for rare disease – The Boston Globe

Read More
Baltimore’s startup revolution – Baltimore Sun

Baltimore’s startup revolution – Baltimore Sun

Read More
BD Life Sciences protozoan panel, receives FDA clearance | Outbreak News Today

BD Life Sciences protozoan panel, receives FDA clearance | Outbreak News Today

Read More
MedImmune, 3M ink launch partnership on next-generation cancer immunotherapy drug – Washington Business Journal

MedImmune, 3M ink launch partnership on next-generation cancer immunotherapy drug – Washington Business Journal

Read More
7 Reasons to Believe in Baltimore’s Startup Economy – Christy Wyskiel

7 Reasons to Believe in Baltimore’s Startup Economy – Christy Wyskiel

Read More
BioFactura Announces the Appointment of Jeffrey N. Hausfeld MD, MBA as the Chairman of the Board and Chief Medical Officer

BioFactura Announces the Appointment of Jeffrey N. Hausfeld MD, MBA as the Chairman of the Board and Chief Medical Officer

Read More
View All Posts